Medicare recently announced it is likely to cover a diabetes prevention program that has been shown to be highly effective. Our Slow Medicine team explains why that’s exciting news for pre-diabetic patients.
Whether it's doctors or restaurants, it turns out that our brains are more likely to be influenced by narrative reviews, such as those on Yelp, than by other rating systems and metrics.
As physicians, we can find evidence in the research literature to support or discourage almost anything. If we don't have a coherent approach to care, it's quite difficult to decide when we have sufficient evidence to change our practice.
In a watershed development on Tuesday, the American Cancer Society announced it was backtracking on its aggressive breast cancer screening recommendations. The new guidelines are much more aligned with the practice of Slow Medicine, and they should change how we talk to patients about screening.
Obamacare has strongly encouraged the creation of accountable care organizations, which focus on coordinating patient care so that, in theory, wasteful practices are eliminated and money is saved. But the early results have been mixed.
When treatment options aren't clear-cut, can decision-making tools such as brochures and videos help patients make better choices? A new study provides the first systematic review of decision aids designed to help patients with serious illness. The evidence on their effectiveness is mixed.
As a new series in Consumer Reports makes clear, antibiotic-resistant infections are becoming more prevalent. The report should be a wake-up call for prescribers and patients to be more thoughtful about how they use antibiotics.
New projections estimate that Obamacare will add more than a quarter-billion dollars in administrative costs by 2022. About two thirds of this added expense will go to private insurance companies via the insurance exchanges. In contrast, public insurance gives far more bang for the buck.
